Sign in

CIK 0001761612

  • Non-accelerated filer
  • Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
  1. 4 Open-market sale Chief Scientific Officer sold 336 shares at $25.10 ($8,434)
  2. 4 Open-market sale Chief Business Officer sold 451 shares at $25.10 ($11,320)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Scientific Officer sold 319 shares at $21.11 ($6,734)
  5. 4 Open-market sale Chief Technology Officer sold 447 shares at $21.11 ($9,436)
  6. 4 Open-market sale Chief Operating Officer sold 447 shares at $21.11 ($9,436)
  7. 4 Open-market sale President and CFO sold 376 shares at $21.11 ($7,937)
  8. 4 Open-market sale Chief Business Officer sold 447 shares at $21.11 ($9,436)
  9. 4 Open-market sale Chief Executive Officer sold 1,486 shares at $21.11 ($31,369)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 5,750 shares (grant or award)
  13. 4 Grant or award Director acquired 5,750 shares (grant or award)
  14. 4 Open-market sale Chief Business Officer sold 1,801 shares at $29.06 ($52,337)
  15. 4 Open-market sale Chief Operating Officer sold 1,801 shares at $29.06 ($52,337)
  16. 4 Open-market sale Chief Medical Officer sold 1,801 shares at $29.06 ($52,337)
  17. 4 Open-market sale Chief Technology Officer sold 1,801 shares at $29.06 ($52,337)
  18. 4 Open-market sale Chief Scientific Officer sold 1,817 shares at $29.06 ($52,802)
  19. 4 Open-market sale President and CFO sold 1,815 shares at $29.06 ($52,744)
  20. 4 Grant or award Director acquired 5,750 shares (grant or award)

Page 8 of 16 · 304 filings